Article
Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations
8 Sept 2021
Abstract excerpt
Although the current coronavirus disease 2019 (COVID-19) vaccines have been used worldwide to halt spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the emergence of new SARS-CoV-2 variants with E484K mutation shows significant resistance to the neutralization of vaccine sera. To better understand the resistant mechanism, we calculated the binding affinities of 26 antibodies to wild-type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
